Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study
暂无分享,去创建一个
K. Syrigos | K. Syrigos | G. Samonis | D. Mavroudis | A. Polyzos | A. Rapti | A. Athanasiadis | K. Kalbakis | A. Rapti | V. Georgoulias | N. Androulakis | M. Agelidou | A. Agelidou | E. Tselepatiotis | J. Nikolakopoulos | G. Samonis